Post Covid 19 – Handling Missing Data in Clinical Trials
COVID-19 disruption of clinical trials is likely to result in missing data, disrupted timelines, and perhaps patient population changes. We thought we would dedicate a blog post to the actions that can be considered when a study is facing the issue of missing data. The COVID-19 situation is clearly still developing and regulators are still…

